Literature DB >> 27886932

Newer Echocardiographic Techniques in Cardiac Resynchronization Therapy.

John Gorcsan1, Bhupendar Tayal2.   

Abstract

Echocardiographic imaging plays a major role in patient selection for cardiac resynchronization therapy (CRT). One-third of patients do not respond; there is interest in advanced echocardiographic imaging to improve response. Current guidelines favor CRT for patients with electrocardiographic (ECG) QRS width of 150 milliseconds or greater and left bundle branch block. ECG criteria are imperfect; there is interest in advanced echocardiographic imaging to improve patient selection. This discussion focuses on newer echocardiographic methods to improve patient selection, improve delivery, and identify patients at risk for poor outcomes and serious ventricular arrhythmias. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac resynchronization therapy; Echocardiography; Heart failure; Ventricular function

Mesh:

Year:  2017        PMID: 27886932     DOI: 10.1016/j.hfc.2016.07.005

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  3 in total

Review 1.  Early Diagnosis of Cardiovascular Diseases in Workers: Role of Standard and Advanced Echocardiography.

Authors:  Lidia Capotosto; Francesco Massoni; Simone De Sio; Serafino Ricci; Antonio Vitarelli
Journal:  Biomed Res Int       Date:  2018-01-16       Impact factor: 3.411

Review 2.  The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.

Authors:  Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Christos Damaskos; Antonios Athanasiou; Efthimios Livanis; Vassilis Voudris
Journal:  Open Cardiovasc Med J       Date:  2017-12-19

3.  Pathophysiology and Current Evidence for Detection of Dyssynchrony.

Authors:  Michael Spartalis; Eleni Tzatzaki; Eleftherios Spartalis; Christos Damaskos; Antonios Athanasiou; Efthimios Livanis; Vassilis Voudris
Journal:  Cardiol Res       Date:  2017-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.